These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 400659)

  • 1. Immunobiology of head and neck cancer: basic concepts.
    Wanebo HJ
    Head Neck Surg; 1979; 2(1):42-55. PubMed ID: 400659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
    Browder JP; Chretien PB
    Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
    [No Abstract]   [Full Text] [Related]  

  • 3. T-cell deficiency in patients with squamous cell cancer of the head and neck.
    Wanebo HJ; Jun MY; Strong EW; Oettgen H
    Am J Surg; 1975 Oct; 130(4):445-51. PubMed ID: 1101724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunopharmacology of head and neck cancer: an update.
    Hadden JW
    Int J Immunopharmacol; 1997; 19(11-12):629-44. PubMed ID: 9669203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy in head and neck cancer: current practice and future possibilities.
    Agada FO; Alhamarneh O; Stafford ND; Greenman J
    J Laryngol Otol; 2009 Jan; 123(1):19-28. PubMed ID: 18761763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immunity in patients with epidermoid cancer of the head and neck.
    Papenhausen PR; Kukwa A; Croft CB; Borowiecki B; Silver C; Emeson EE
    Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in Immunotherapy of Head and Neck Squamous Cell Carcinoma.
    Almokadem S
    Curr Mol Pharmacol; 2016; 9(3):226-230. PubMed ID: 26177644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options.
    Moskovitz JM; Moy J; Seiwert TY; Ferris RL
    Oncologist; 2017 Jun; 22(6):680-693. PubMed ID: 28507203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma].
    Bron L; Romero P
    Bull Cancer; 2007 Sep; 94(9):793-7. PubMed ID: 17878099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
    Bier J; Bitter K; Nicklisch U
    J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology of head and neck cancers.
    Newbill ET; Johns ME
    Crit Rev Clin Lab Sci; 1983; 19(1):1-25. PubMed ID: 6201320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Immunology and Immunotherapy for Head and Neck Squamous Cell Carcinoma.
    Moskovitz JM; Ferris RL
    J Dent Res; 2018 Jun; 97(6):622-626. PubMed ID: 29489423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic evaluation and prognosis in patients with head and neck cancer.
    Hilal EY; Wanebo HJ; Pinsky CM; Middleman P; Strong EW; Oettgen HF
    Am J Surg; 1977 Oct; 134(4):468-73. PubMed ID: 303057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunobiology and immunotherapy of head and neck cancer.
    Whiteside TL
    Curr Oncol Rep; 2001 Jan; 3(1):46-55. PubMed ID: 11123869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of immunity in cancer patients by prostaglandin antagonists.
    Braun DP; Taylor SG; Harris JE
    Prog Clin Biol Res; 1989; 288():439-48. PubMed ID: 2785695
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunotherapy for Head and Neck Cancer.
    Sim F; Leidner R; Bell RB
    Oral Maxillofac Surg Clin North Am; 2019 Feb; 31(1):85-100. PubMed ID: 30449528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of head and neck cancer.
    Resser JR; Carbone DP
    Curr Opin Oncol; 1998 May; 10(3):226-32. PubMed ID: 9619359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
    Olkowski ZL; McLaren JR; Skeen MJ
    Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for head and neck cancer patients: shifting the balance.
    Turksma AW; Braakhuis BJ; Bloemena E; Meijer CJ; Leemans CR; Hooijberg E
    Immunotherapy; 2013 Jan; 5(1):49-61. PubMed ID: 23256798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of squamous head and neck carcinoma. Immunologic aberrations in patients who develop recurrent disease.
    Huang AT; Mold NG; Fisher SR; Brantley BA; Cole TB; Wallman MJ; Crocker IR
    Cancer; 1987 May; 59(10):1721-6. PubMed ID: 2950991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.